IFN-γ regulates Fas ligand expression in human CD4+ T lymphocytes and controls their anti-mycobacterial cytotoxic functions

European Journal of Immunology

Volumn 37, Issue 8, 2007, Pages 2196-2204

  Boselli, Daniela ^a,b   Losana, Giuliana ^a   Bernabei, Paola ^b   Bosisio, Daniela ^c   Drysdale, Pamela ^d   Kiessling, Rolf ^e   Gaston, John S H ^f   Lammas, David ^d   Casanova, Jean Laurent ^g   Kumararatne, Dinakantha S ^f   Novelli, Francesco ^a,b  

^a UNIVERSITY OF TURIN   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

^c UNIVERSITY OF BRESCIA   (Italy)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^e KAROLINSKA INSTITUTE   (Sweden)

^f ADDENBROOKE S HOSPITAL   (United Kingdom)

^g IMAGINE INSTITUTE   (France)

Author keywords

Apoptosis; Bacterial infection; Cytokine; Human T cells

Indexed keywords

BACTERIAL ANTIGEN; FAS LIGAND; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; GAMMA INTERFERON RECEPTOR 1; UNCLASSIFIED DRUG;

ANTIGEN SPECIFICITY; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOTOXICITY; EFFECTOR CELL; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNOREGULATION; LEUKEMIA CELL LINE; LYMPHOBLAST; MACROPHAGE ACTIVATION; MOLECULAR CLONING; MYCOBACTERIOSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANTIGENS, CD95; APOPTOSIS; CD4-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; FAS LIGAND PROTEIN; FLOW CYTOMETRY; HUMANS; INTERFERON TYPE II; MICROSCOPY, CONFOCAL; MYCOBACTERIUM; MYCOBACTERIUM INFECTIONS; RECEPTORS, INTERFERON; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 34547919957     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200636541     Document Type: Article

References (46)

1. Green, D. R., Droin, N. and Pinkoski, M., Activation-induced cell death in T cells. Immunol. Rev. 2003. 193: 70-81.
2. Krueger, A., Fas, S. C., Baumann, S. and Krammer, P. H., The role of CD95 in the regulation of peripheral T-cell apoptosis. Immunol. Rev. 2003. 193: 58-69.
3. Pestka, S., Kotenko, S. V., Muthukumaran, G., Izotova, L. S., Cook, J. R. and Garotta, G., The interferon gamma (IFN-gamma) receptor: A paradigm for the multichain cytokine receptor. Cytokine Growth Factor Rev. 1997. 8: 189-206.
4. Casanova, J. L. and Abel, L., The human model: A genetic dissection of immunity to infection in natural conditions. Nat. Rev. Immunol. 2004. 4: 55-66.
5. Liu, Y. and Janeway, C. A., Jr., Interferon gamma plays a critical role in induced cell death of effector T cell: A possible third mechanism of self-tolerance. J. Exp. Med. 1990. 172: 1735-1739.
6. Chu, C. Q., Wittmer, S. and Dalton, D. K., Failure to suppress the expansion of the activated CD4 T cell population in interferon gamma-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis. J. Exp. Med. 2000. 192: 123-128.
7. Dalton, D. K., Haynes, L., Chu, C. Q., Swain, S. L and Wittmer, S., Interferon gamma eliminates responding CD4 T cells during mycobacterial infection by inducing apoptosis of activated CD4 T cells. J. Exp. Med. 2000. 192: 117-122.
8. Refaeli, Y., Van Parijs, L., Alexander, S. I. and Abbas, A. K., Interferon gamma is required for activation-induced death of T lymphocytes. J. Exp. Med. 2002. 196: 999-1005.
9. Regis, G., Conti, L., Boselli, D. and Novelli, F., IFNgammaR2 trafficking tunes IFNgamma-STAT1 signaling in T lymphocytes. Trends Immunol. 2006. 27: 96-101.
10. Oyaizu, N., McCloskey, T. W., Than, S., Hu, R., Kalyanaraman, V. S. and Pahwa, S., Cross-linking of CD4 molecules upregulates Fas antigen expression in lymphocytes by inducing interferon-gamma and tumor necrosis factor-alpha secretion. Blood 1994. 84: 2622-2631.
11. Novelli, F., D'Elios, M. M., Bernabei, P., Ozmen, L., Rigamonti, L., Almerigogna, F., Forni, G. and Del Prete, G., Expression and role in apoptosis of the alpha- and beta-chains of the IFN-gamma receptor on human Th1 and Th2 clones. J. Immunol. 1997. 159: 206-213.
12. Martins, G. A., Vieira, L. Q., Cunha, F. Q. and Silva, J. S., Gamma interferon modulates CD95 (Fas) and CD95 ligand (Fas-L) expression and nitric oxide-induced apoptosis during the acute phase of Trypanosoma cruzi infection: A possible role in immune response control. Infect. Immun. 1999. 67: 3864-3871.
13. De Rose, V., Cappello, P., Sorbello, V., Ceccarini, B., Gani, F., Bosticardo, M., Fassio, S. and Novelli, F., IFN-gamma inhibits the proliferation of allergen-activated T lymphocytes from atopic, asthmatic patients by inducing Fas/FasL-mediated apoptosis. J. Leukoc. Biol. 2004. 76: 423-432.
14. Reichenbach, J., Rosenzweig, S., Doffinger, R., Dupuis, S., Holland, S. M. and Casanova, J. L., Mycobacterial diseases in primary immunodeficiencies. Curr. Opin. Allergy Clin. Immunol. 2001. 1: 503-511.
15. Nagata, S. and Suda, T., Fas and Fas ligand: Ipr and gld mutations. Immunol. Today 1995. 16: 39-43.
16. Rieux-Laucat, F., Le Deist, F. and Fischer, A., Autoimmune lymphoproliferative syndromes: Genetic defects of apoptosis pathways. Cell Death Differ. 2003. 10: 124-133.
17. Oddo, M., Renno, T., Attinger, A., Bakker, T., MacDonald, H. R. and Meylan, P. R., Fas ligand-induced apoptosis of infected human macrophages reduces the viability of intracellular Mycobacterium tuberculosis. J. Immunol. 1998. 160: 5448-5454.
18. Novelli, F., Bernabei, P., Ozmen, L., Rigamonti, L., Allione, A., Pestka, S., Garotta, G. and Forni, G., Switching on of the proliferation or apoptosis of activated human T lymphocytes by IFN-gamma is correlated with the differential expression of the alpha- and beta-chains of its receptor. J. Immunol. 1996. 157: 1935-1943.
19. Suda, T., Okazaki T., Naito, Y., Yokota, T., Arai, N., Ozaki, S., Nakao, K. and Nagata, S., Expression of the Fas ligand in cells of T cell lineage. J. Immunol. 1995. 154: 3806-3813.
20. Bossi, G. and Griffiths, G. M., Degranulation plays an essential part in regulating cell surface expression of Fas ligand in T cells and natural killer cells. Nat. Med. 1999. 5: 90-96.
21. Rigamonti, I., Ariotti, S., Losana G., Gradini R., Russo, M. A., Jouanguy, E., Casanova, J. L. et al., Surface expression of the IFN-gamma R2 chain is regulated by intracellular trafficking in human T lymphocytes. J. Immunol. 2000. 164: 201-207.
22. Bernabei, P., Coccia, E. M., Rigamonti, L., Bosticardo, M., Forni, G., Pestka, S., Krause, C. D. et al., Interferon-gamma receptor 2 expression as the deciding factor in human T, B, and myeloid cell proliferation or death. J. Leukoc. Biol. 2001. 70: 950-960.
23. Blott, E. J., Bossi, G., Clark, R., Zvelebil, M. and Griffiths, G. M., Fas ligand is targeted to secretory lysosome via a proline-rich domain in its cytoplasmic tail. J. Cell Sci. 2001. 114: 2405-2416.
24. Muroi, M., Shiragami, N., Nagao, K., Yamasaki, M. and Takatsuki, A., Folimycin (concanamycin A), a specific inhibitor of V-ATPase, blocks intracellular translocation of the glycoprotein of vesicular stomatitis virus before arrival to the Golgi apparatus. Cell Struct. Funct. 1993. 18: 139-149.
25. Haddad, E. K., Wu, X., Hammer, J. A., 3rd and Henkart, P. A., Defective granule exocytosis in Rab27a-deficient lymphocytes from Ashen mice. J. Cell Biol. 2001. 152: 835-842.
26. Lettau, M., Qian, J., Linkermann, A., Lattreille, M., Larose, L., Kabelitz, D. and Janssen, O., The adaptor protein Nck interacts with Fas ligand: Guiding the death factor to the cytotoxic immunological synapse. Proc. Natl. Acad. Sci. USA 2006. 103: 5911-5916.
27. Alvarez-Dominguez, C. and Stahl, P. D., Interferon-gamma selectively induces Rab5a synthesis and processing in mononuclear cells. J. Biol. Chem. 1998. 273: 33901-33904.
28. Chow, W. A., Fang, J. J. and Yee, J. K., The IFN regulatory factor family participates in regulation of Fas ligand gene expression in T cells. J. Immunol. 2000. 164: 3512-3518.
29. + T cell homeostasis by perforin and interferon-gamma. Science 2000. 290: 1354-1358.
30. + T cells initiate IFN-gamma synthesis increases markedly over the course of infection and correlates with immunodominance. J. Immunol. 2004. 173: 456-462.
31. + T cells to increase their abundance during virus infection. J. Exp. Med. 2005. 201: 1053-1059.
32. + cytotoxic T lymphocytes that lyse human monocytes. J. Exp. Med. 1988. 168: 1947-1952.
33. + phenotype. Enhancement by the cutaneous administration of interleukin 2. J. Exp. Med. 1989. 169: 909-919.
34. + cytotoxic T cell clones. A novel potentially immunoregulatory T-T cell interaction in man. J. Exp. Med. 1990. 171: 2011-2024.
35. + T-cell clones: Heterogeneity in antigen recognition, cytokine production, and cytotoxicity for mononuclear phagocytes. Infect. Immun. 1991. 59: 2737-2743.
36. Silva, C. L. and Lowrie, D. B., Identification and characterization of murine cytotoxic T cells that kill Mycobacterium tuberculosis. Infect. Immun. 2000. 68: 3269-3274.
37. + T cells use both CD95-dependent and CD95-independent cytolytic mechanism. J. Immunol. 1998. 160: 2374-2379.
38. Fayyazi, A., Eichmeyer, B., Soruri, A., Schweyer, S., Herms, J., Schwarz, P. and Radzun, H. J., Apoptosis of macrophages and T cells in tuberculosis associated caseous necrosis. J. Pathol. 2000. 191: 417-425.
39. + HLA-DR-restricted cytotoxic T lymphocytes as well as nonspecific nonrestricted killer cells by the recombinant mycobacterial 65-kDa heat-shock protein. Eur. J. Immunol. 1990. 20: 369-377.
40. Kumararatne, D. S., Pithie, A. S., Drysdale, P., Gaston, J. S., Kiessling, R., Iles, P. B., Ellis, C. J. et al., Specific lysis of mycobacterial antigen-bearing macrophages by class II MHC-restricted polyclonal T cell lines in healthy donors or patients with tuberculosis. Clin. Exp. Immunol. 1990. 80: 314-323.
41. Pithie, A. D., Rahelu, M., Kumararatne, D. S., Drysdale, P., Gaston, J. S., Iles, P. B., Innes, J. A. and Ellis, C. J., Generation of cytolytic T cells in individuals infected by Mycobacterium tuberculosis and vaccinated with BCG. Thorax 1992. 47: 695-701.
42. Ochoa, M. T., Stenger, S., Sieling, P. A., Thoma-Uszynski, S., Sabet, S., Cho, S., Krensky, A. M. et al., T-cell release of granulysin contributes to host defense in leprosy. Nat. Med. 2001. 7: 174-179.
43. Losana, G., Rigamonti, L., Borghi, I., Assenzio, B., Ariotti, S., Jouanguy, E., Altare, F. et al., Requirement for both IL-12 and IFN-gamma signaling pathways in optimal IFN-gamma production by human T cells. Eur. J. Immunol. 2002. 32: 693-700.
44. Eischen, C. M., Schilling, J. D., Lynch, D. H., Krammer, P. H. and Leibson, P. J., Fc receptor-induced expression of Fas ligand on activated NK cells facilitates cell-mediated cytotoxicity and subsequent autocrine NK cell apoptosis. J. Immunol. 1996. 156: 2693-2699.
45. Jouanguy, E., Lamhamedi-Cherradi, S., Lammas, D., Dorman, S. E., Fondaneche, M. C., Dupuis, S., Doffinger, R. et al., A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection. Nat. Genet. 1999. 21: 370-378.
46. Dorman, S. E., Picard, C., Iamma, D., Heyne, K., van Dissel, J. T., Baretto, R., Rosenzweig, S. D. et al., Clinical features of dominant and recessive interferon gamma receptor 1 deficiencies. Lancet 2004. 364: 2113-2121.